Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies.
Despina FotiouFoteini TheodorakakouMaria GavriatopoulouMagdalini MigkouPanagiotis MalandrakisIoannis Ntanasis-StathopoulosNikolaos KanelliasEvangelos Eleutherakis PapaiakovouEvangelos TerposAsimina PapanikolaouCharikleia GakiopoulouMeletios- Athanasios DimopoulosEfstathios KastritisPublished in: European journal of haematology (2023)
Our data support the use of targeted therapies for patients with t(11;14) to avoid delays in the achievement of deep hematologic responses.